These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Staging and survival in multiple myeloma. Wahlin A. Scand J Haematol; 1984 Jul; 33(1):22-6. PubMed ID: 6463584 [Abstract] [Full Text] [Related]
49. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma. Scudla V, Lochman P, Pika T, Minarik J, Zapletalova J, Bacovsky J. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929 [Abstract] [Full Text] [Related]
51. The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function. Dimopoulos MA, Kastritis E, Michalis E, Tsatalas C, Michael M, Pouli A, Kartasis Z, Delimpasi S, Gika D, Zomas A, Roussou M, Konstantopoulos K, Parcharidou A, Zervas K, Terpos E, Greek Myeloma Study Group. Ann Oncol; 2012 Mar; 23(3):722-729. PubMed ID: 21652580 [Abstract] [Full Text] [Related]
52. Erythropoiesis-stimulating agents are associated with reduced survival in patients with multiple myeloma. Katodritou E, Verrou E, Hadjiaggelidou C, Gastari V, Laschos K, Kontovinis L, Kapetanos D, Constantinou N, Terpos E, Zervas K. Am J Hematol; 2008 Sep; 83(9):697-701. PubMed ID: 18626886 [Abstract] [Full Text] [Related]
55. The Role of 18F-FDG PET/CT in Multiple Myeloma Staging according to IMPeTUs: Comparison of the Durie-Salmon Plus and Other Staging Systems. Deng S, Zhang B, Zhou Y, Xu X, Li J, Sang S, Zhang W. Contrast Media Mol Imaging; 2018 Sep; 2018():4198673. PubMed ID: 30154686 [Abstract] [Full Text] [Related]
56. Multiple myeloma in the region of Bursa, Turkey: a retrospective analysis. Ozkalemkaş F, Ali R, Tunali A, Ozkocaman V, Ozyardimci C, Ozçelik T. J Environ Pathol Toxicol Oncol; 1996 Sep; 15(2-4):267-70. PubMed ID: 9216819 [Abstract] [Full Text] [Related]